ホームポートフォリオウォッチリストコミュニティ発見スクリーナー
NOT FOR DISTRIBUTION

Cabot Corporation

NYSE:CBT 株式レポート

時価総額:US$4.1b

  • 会社概要
  • 評価
  • 将来の成長
  • 過去の実績
  • 財務の健全性
  • 配当金
  • マネジメント
  • 所有権
  • その他の情報
  • 株式コミュニティ

Cabot 将来の成長

Future 基準チェック /46

Cabot利益と収益がそれぞれ年間57.8%と3.7%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に21.2% 58.9%なると予測されています。

主要情報

57.8%

収益成長率

58.88%

EPS成長率

Chemicals 収益成長21.8%
収益成長率3.7%
将来の株主資本利益率21.18%
アナリストカバレッジ

Good

最終更新日23 Aug 2026

今後の成長に関する最新情報

Recent updates

User avatar
ナラティブ更新 • Aug 16

CBT: Rising Carbon Black Concerns Will Drive A Weaker Future Profile

Cabot's analyst price target has moved up from $70.37 to $78.00, with analysts pointing to updated views on revenue growth, profitability, and P/E assumptions following recent research that includes higher price objectives of $90 and $100, along with positive commentary on the battery materials and Performance Chemicals businesses. Analyst Commentary Recent research on Cabot has centered on how the stock trades relative to its P/E assumptions and perceived growth potential in key businesses such as battery materials and Performance Chemicals.
Seeking Alpha • Aug 04

Cabot Corporation: Successful Returns, Downgrading Into 2027-2028E (Downgrade)

Summary Cabot Corporation is now fairly valued after a period of significant undervaluation and strong operational outperformance. I downgrade CBT to Hold with a new price target of $82/share, as the current upside is limited following a 20-30% rally. CBT’s disciplined capital allocation, low leverage, and resilient margins underpin its stability despite cyclical end-market pressures. Future growth hinges on recovery in reinforcement materials and continued strength in performance chemicals, but macro risks constrain further upside. Read the full article on Seeking Alpha
User avatar
新しいナラティブ • Aug 02

Battery Materials Competition And Cost Pressures Will Limit Long-Term Earnings Potential

Catalysts About Cabot Cabot Corporation produces specialty chemicals and materials including reinforcement materials, performance chemicals and battery materials that serve a range of industrial and energy storage applications. What are the underlying business or industry changes driving this perspective?
User avatar
ナラティブ更新 • Jun 26

CBT: Battery Materials And Buybacks Will Shape Balanced Medium-Term Outlook

Analysts have nudged their fair value estimate for Cabot higher to $88.50 from $85.67, citing updated price targets in the $70 to $98 range and renewed attention on the company’s battery materials, Reinforcement Materials, and Performance Chemicals businesses. Analyst Commentary Recent Street commentary on Cabot gives a mixed but useful read on how professionals are weighing the company’s earnings potential, valuation, and execution across its key segments, especially battery materials, Reinforcement Materials, and Performance Chemicals.
User avatar
新しいナラティブ • Jun 23

Battery And Data Center Demand Will Drive Long-Term Upside Potential

Catalysts About Cabot Cabot develops specialty materials, including reinforcement and performance chemicals used across tires, batteries and broader industrial applications. What are the underlying business or industry changes driving this perspective?
分析記事 • Jun 21

Cabot (CBT) Stock Could Be 7.2% Overvalued After Sixth Straight EcoVadis Platinum Rating

Cabot (CBT) has drawn fresh attention after receiving a platinum rating from EcoVadis for the sixth consecutive year, placing the company among the top 1% of peers in environmental, social, and governance practices. See our latest analysis for Cabot. The EcoVadis recognition has arrived during a strong run in Cabot’s stock, with a 34.09% 3 month share price return and a 28.47% 1 year total shareholder return, which may indicate building momentum rather than a short lived spike. If Cabot’s...
User avatar
新しいナラティブ • Jun 09

Battery And Data Center Demand Will Support A Steady Long Term Materials Story

Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?
分析記事 • Nov 03

Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...
分析記事 • Sep 11

Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch

With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...
分析記事 • Jul 20

Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?

Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...
分析記事 • Jun 23

Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
分析記事 • Apr 25

These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Apr 10

Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price

Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...
分析記事 • Mar 12

A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price

Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...
Seeking Alpha • Feb 13

Cabot Corporation: Reinforcing Positive Shareholder Value

Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking Alpha
Seeking Alpha • Jan 30

Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)

Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking Alpha
分析記事 • Jan 29

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...
分析記事 • Jan 15

Is Cabot (NYSE:CBT) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • Jan 02

Returns On Capital Are A Standout For Cabot (NYSE:CBT)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
分析記事 • Dec 06

Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...
Seeking Alpha • Nov 14

Cabot: Less Than 5% Annualized Upside

Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking Alpha
分析記事 • Oct 31

Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
分析記事 • Oct 19

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...
分析記事 • Oct 07

Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...

業績と収益の成長予測

NYSE:CBT - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
9/30/20283,923N/A2615515
9/30/20273,7963782525176
9/30/20263,6832262034436
6/30/20263,634187281497N/A
3/31/20263,575281432671N/A
12/31/20253,607306401667N/A
9/30/20253,713326364665N/A
6/30/20253,815418321650N/A
3/31/20253,908426288608N/A
12/31/20243,991417420711N/A
9/30/20243,994374451692N/A
6/30/20243,958470399626N/A
3/31/20243,910443407662N/A
12/31/20233,924433385648N/A
9/30/20233,931437351595N/A
6/30/20234,078300306562N/A
3/31/20234,259315127353N/A
12/31/20224,318348-15201N/A
9/30/20224,321206-111100N/A
6/30/20224,113142-10695N/A
3/31/20223,881130-65132N/A
12/31/20213,63198-9187N/A
9/30/20213,40924762257N/A
6/30/20213,164-54103256N/A
3/31/20212,765-144184334N/A
12/31/20202,633-219132293N/A
9/30/20202,614-238177377N/A
6/30/20202,78265244475N/A
3/31/20203,109103N/A441N/A
12/31/20193,243127N/A507N/A
9/30/20193,337155N/A363N/A
6/30/20193,360217N/A321N/A
3/31/20193,369273N/A268N/A
12/31/20183,34377N/A214N/A
9/30/20183,242-114N/A298N/A
6/30/20183,115-136N/A300N/A
3/31/20182,966-177N/A371N/A
12/31/20172,82669N/A286N/A
9/30/20172,717246N/A348N/A
6/30/20172,613225N/A288N/A
3/31/20172,529234N/A262N/A
12/31/20162,419209N/A416N/A
9/30/20162,411145N/A392N/A
6/30/20162,463136N/A516N/A
3/31/20162,536-366N/A482N/A
12/31/20152,662-388N/A526N/A
9/30/20152,871-336N/A499N/A

アナリストによる今後の成長予測

収入対貯蓄率: CBTの予測収益成長率 (年間57.8% ) は 貯蓄率 ( 3.7% ) を上回っています。

収益対市場: CBTの収益 ( 57.8% ) はUS市場 ( 17.4% ) よりも速いペースで成長すると予測されています。

高成長収益: CBTの収益は今後 3 年間で 大幅に 増加すると予想されています。

収益対市場: CBTの収益 ( 3.7% ) US市場 ( 13.5% ) よりも低い成長が予測されています。

高い収益成長: CBTの収益 ( 3.7% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: CBTの 自己資本利益率 は、3年後には高くなると予測されています ( 21.2 %)


成長企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/09/09 07:00
終値2026/09/09 00:00
収益2026/06/30
年間収益2025/09/30

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
  • SECフォーム10-K
  • SECフォーム10-Q
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
  • アナリストリサーチレポート
  • Blue Matrix
市場価格30年
  • 株価
  • 配当、分割、措置
  • ICEマーケットデータ
  • SECフォームS-1
所有権10年
  • トップ株主
  • インサイダー取引
  • SECフォーム4
  • SECフォーム13D
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
  • SECフォーム10-K
  • SECフォームDEF 14A
主な進展10年
  • 会社からのお知らせ
  • SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Cabot Corporation 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11

アナリスト機関
Benjamin KalloBaird
Michael LeitheadBarclays
David BegleiterDeutsche Bank

どこでもより良い投資判断を

スキャンしてダウンロード
App Store を開くGoogle Play を開く
Chrome ウェブストア
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
データソースを見る
市場
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
投資のアイデア
  • 割安企業
  • 配当優良企業
  • インサイダー買い
  • 原子力
  • 自律走行車
  • 人工知能
  • 暗号資産とブロックチェーン
  • サイバーセキュリティ
  • さらにアイデア
株価コミュニティ
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
機能とツール
  • ポートフォリオ・トラッカー
  • ストックスクリーナー&アラート
  • 語りと公正な値
  • 配当金計算機
ニュース & 発見
  • 最新の在庫ニュース
  • グローバルマーケットインサイト
  • The Foxhole ブログ
  • 投資のアイデア
  • コミュニティの物語
  • 新着情報
Simply Wall St
  • プランと料金
  • 広告
  • 会社概要
  • お問い合わせ
  • 採用情報
  • ヘルプセンター
  • 株式投資を学ぶ
  • アフィリエイト・プログラム
  • ビジネス
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • ご利用条件
  • プライバシーポリシー
  • AI利用規約
  • 金融サービスガイド